TY - JOUR
T1 - Clinical and electrographic features of persistent seizures and status epilepticus associated with anti-NMDA receptor encephalitis (anti-NMDARE)
AU - Gofshteyn, Jacqueline S.
AU - Yeshokumar, Anusha K.
AU - Jette, Nathalie
AU - Thakur, Kiran T.
AU - Luche, Nicole
AU - Yozawitz, Elissa
AU - Varnado, Shelley
AU - Klenofsky, Britany
AU - Tuohy, Mary Claire
AU - Ankam, Jyoti
AU - Torres, Sarah
AU - Hesdorffer, Dale
AU - Nelson, Aaron
AU - Wolf, Steven
AU - McGoldrick, Patricia
AU - Yan, Helena
AU - Basma, Natasha
AU - Grinspan, Zachary
N1 - Publisher Copyright:
© 2020 Epileptic Disorders
PY - 2020/12
Y1 - 2020/12
N2 - Aims. Based on a multicenter cohort of people with anti-NMDA receptor encephalitis (anti-NMDARE), we describe seizure phenotypes, electroencephalographic (EEG) findings, and anti-seizure treatment strategies. We also investigated whether specific electrographic features are associated with persistent seizures or status epilepticus after acute presentation. Methods. In this retrospective cohort study, we reviewed records of children and adults with anti-NMDARE between 2010 and 2014 who were included in the Rare Epilepsy of New York City database, which included the text of physician notes from five academic medical centers. Clinical history (e.g., seizure semiology) and EEG features (e.g., background organization, slowing, epileptiform activity, seizures, sleep architecture, extreme delta brush) were abstracted. We compared clinical features associated with persistent seizures (ongoing seizures after one month from presentation) and status epilepticus, using bivariate and multivariable analyses. Results. Among the 38 individuals with definite anti-NMDARE, 32 (84%) had seizures and 29 (76%) had seizures captured on EEG. Electrographic-only seizures were identified in five (13%) individuals. Seizures started at a median of four days after initial symptoms (IQR: 3–6 days). Frontal lobe-onset focal seizures were most common (n=12; 32%). Most individuals (31/38; 82%) were refractory to anti-seizure medications. Status epilepticus was associated with younger age (15 years [9–20] vs. 23 years [18–27]; p=0.04) and Hispanic ethnicity (30 [80%] vs. 8 [36%]; p=0.04). Persistent seizures (ongoing seizures after one month from presentation) were associated with younger age (nine years [3–14] vs. 22 years [15–28]; p<0.01). Measured electrographic features were not associated with persistent seizures. Conclusions. Seizures associated with anti-NMDARE are primarily focal seizures originating in the frontal lobes. Younger patients may be at increased risk of epileptogenesis and status epilepticus. Continuous EEG monitoring helps identify subclinical seizures, but specific EEG findings may not predict the severity or persistence of seizures during hospitalization.
AB - Aims. Based on a multicenter cohort of people with anti-NMDA receptor encephalitis (anti-NMDARE), we describe seizure phenotypes, electroencephalographic (EEG) findings, and anti-seizure treatment strategies. We also investigated whether specific electrographic features are associated with persistent seizures or status epilepticus after acute presentation. Methods. In this retrospective cohort study, we reviewed records of children and adults with anti-NMDARE between 2010 and 2014 who were included in the Rare Epilepsy of New York City database, which included the text of physician notes from five academic medical centers. Clinical history (e.g., seizure semiology) and EEG features (e.g., background organization, slowing, epileptiform activity, seizures, sleep architecture, extreme delta brush) were abstracted. We compared clinical features associated with persistent seizures (ongoing seizures after one month from presentation) and status epilepticus, using bivariate and multivariable analyses. Results. Among the 38 individuals with definite anti-NMDARE, 32 (84%) had seizures and 29 (76%) had seizures captured on EEG. Electrographic-only seizures were identified in five (13%) individuals. Seizures started at a median of four days after initial symptoms (IQR: 3–6 days). Frontal lobe-onset focal seizures were most common (n=12; 32%). Most individuals (31/38; 82%) were refractory to anti-seizure medications. Status epilepticus was associated with younger age (15 years [9–20] vs. 23 years [18–27]; p=0.04) and Hispanic ethnicity (30 [80%] vs. 8 [36%]; p=0.04). Persistent seizures (ongoing seizures after one month from presentation) were associated with younger age (nine years [3–14] vs. 22 years [15–28]; p<0.01). Measured electrographic features were not associated with persistent seizures. Conclusions. Seizures associated with anti-NMDARE are primarily focal seizures originating in the frontal lobes. Younger patients may be at increased risk of epileptogenesis and status epilepticus. Continuous EEG monitoring helps identify subclinical seizures, but specific EEG findings may not predict the severity or persistence of seizures during hospitalization.
KW - anti-NMDA receptor encephalitis
KW - autoimmune encephalitis
KW - seizure risk factors
UR - http://www.scopus.com/inward/record.url?scp=85099428567&partnerID=8YFLogxK
U2 - 10.1684/epd.2020.1218
DO - 10.1684/epd.2020.1218
M3 - Article
C2 - 33258455
AN - SCOPUS:85099428567
SN - 1294-9361
VL - 22
SP - 739
EP - 751
JO - Epileptic Disorders
JF - Epileptic Disorders
IS - 6
ER -